When the focus moves more specifically to diseases, c-myb is identified as a target in glioma stem cells for glioblastoma multiforme (GBM) therapy, in which expression was considerably elevated in GBM tissues relative to normal tissues [202]. The gene discussed is MYB; the disease is glioblastoma.